ACET - Adicet Bio - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACET is currently covered by 9 analysts with an average price target of $8.12. This is a potential upside of $7.51 (1231.15%) from yesterday's end of day stock price of $0.61.

Adicet Bio's activity chart (see below) currently has 19 price targets and 51 ratings on display. The stock rating distribution of ACET is 79.41% BUY and 20.59% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 3.33% with an average time for these price targets to be met of 23.9 days.

Highest price target for ACET is $8, Lowest price target is $5, average price target is $7.33.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 19-Dec-2024. First documented stock forecast 20-Feb-2018.

Currently out of the existing stock ratings of ACET, 27 are a BUY (79.41%), 7 are a HOLD (20.59%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4 months 21 days ago
(19-Dec-2024)

0/10 (0%)

$8.63 (629.93%)

Buy

$7

$5.89 (530.63%)

7 months 10 days ago
(30-Sep-2024)

0/3 (0%)

$5.56 (386.11%)

Buy

$5

$3.89 (350.45%)

$5

7 months 20 days ago
(20-Sep-2024)

0/7 (0%)

$3.47 (226.80%)

Buy

$8

$6.89 (620.72%)

$19

7 months 29 days ago
(11-Sep-2024)

0/4 (0%)

$6.57 (459.44%)

Buy

$8

$6.89 (620.72%)

$27

1 years 4 months 5 days ago
(05-Jan-2024)

0/2 (0%)

$5.58 (230.58%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACET (Adicet Bio) average time for price targets to be met?

On average it took 23.9 days on average for the stock forecasts to be realized with a an average price target met ratio 3.33

Which analyst has the current highest performing score on ACET (Adicet Bio) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on ACET (Adicet Bio)?

Robert Driscoll works at WEDBUSH and has 0 price targets and 5 ratings on ACET

Which analyst is the currently most bullish on ACET (Adicet Bio)?

David Dai with highest potential upside - $10.8

Which analyst is the currently most reserved on ACET (Adicet Bio)?

Reni Benjamin with lowest potential downside - -$0

Adicet Bio in the News

Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

REDWOOD CITY, Calif. & BOSTON, January 25, 2024–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the closing of its previously announced underwritten public offering of 32,379,667 shares of its common stock, which includes 5,325,000 shares sold...

Adicet Bio, Inc. Announces Pricing of Public Offering

REDWOOD CITY, Calif. & BOSTON, January 23, 2024–(BUSINESS WIRE)–Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the pricing of an underwritten public offering of 27,054,667 shares of its common stock and, in lieu of common stock...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?